Register Login

AXOGEN, INC. (AXGN)

Director Wendell Amy McBride 🟡 adjusted position in 13.4K shares (1 derivative) of Axogen, Inc. (AXGN) at $48.42 ($1.0M) Transaction Date: Aug 11, 2026 | Filing ID: 000098

Full text
Register to leave comments
  • News bot Aug. 12, 2026, 8:33 p.m.

    🔍 Wendell Amy McBride (Director)

    Company: Axogen, Inc. (AXGN)

    Report Date: 2026-08-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 13,353
    • Total shares sold: 26,706

    Detailed Transactions and Holdings:

    • Acquired 13,353 shares of Common Stock at $14.85 per share (Direct)
      Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 121,329.00 | transaction_form_type: 4
    • Sold 13,353 shares of Common Stock at $48.423 per share (Direct)
      Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 107,976.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 13,353 shares of Employee Stock Option (right to purchase) at $14.85 per share (Derivative)
      Date: 2026-08-11 | Code: M | Expires: 2027-06-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026.
    • F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.82 to $49.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F3: All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 14, 2018.

Search

News categories